Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

French surgeons welcome back breast prostheses:

This article was originally published in Clinica

Executive Summary

French surgeons have welcomed the lifting of the five-year ban on silicone breast implants. They claim there is no proof of a link between silicone and cancer or autoimmune diseases and point out that the quality of implants has improved both in terms of resistance and lifespan. Some 150,000-200,000 French women have had breast implants over the 35 years they have been available. French surgeons estimate that the number of cosmetic, rather than reconstructive, cases represents 60%. The real figure is more likely to be 80%, according to Le Quotidien du Medecin.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070007

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel